KUWAIT CITY, June 15, 2026 /PRNewswire/ -- Action Energy Company K.S.C.P. (Bloomberg: ALFTAQA KK, Reuters: ALFTAQA.KW), Kuwait's leading local partner for integrated upstream services, owner and operator of one of the youngest rig fleets in the region, announced on May 20, 2026 the signing of a market maker agreement with National Investments Company (NIC).
This step builds on the strong investor reception to Action Energy Company's (AEC) initial public offering, and aims to enhance trading liquidity for shareholders following the Company's successful listing as one of Kuwait's leading upstream oilfield services and drilling companies supporting the country's crude oil production sector.
Under the agreement, NIC will enter paired buy and sell orders on AEC's shares during trading sessions, within a defined price spread and minimum order size, and at no less than a specified percentage of total monthly trading value. These arrangements are expected to enhance liquidity and support continuous supply and demand for the "ALFTAQA" share on Boursa Kuwait, improving market depth and accessibility for investors seeking exposure to Kuwait's upstream oil and gas sector.
NIC acted as Sole Listing Advisor, Sole Subscription Agent, Joint Global Coordinator, and Joint Bookrunner for AEC's IPO and its listing on the Premier Market of Boursa Kuwait in December 2025. The offering attracted strong demand from local and international investors, with subscriptions exceeding the offered value by 5.0 times, with an initial coverage value of KWD 276 million, reflecting investor confidence in Kuwait's energy sector, upstream drilling market, and long-term crude oil production growth plans.
AEC enters the remainder of 2026 with strong revenue visibility supported by a substantial multi-year contracted backlog with KOC, full fleet utilization, and a pipeline of new rig deployments and oilfield services contracts under mobilization.
AEC employs more than 1,700 professionals and operates 20 rigs across Kuwait, delivering a comprehensive range of integrated drilling, workover, and oilfield services, covering the full well lifecycle, including workover, directional drilling, slickline, coiled tubing, cementing, mud engineering, electric submersible pumps (ESP), inspection (NDT), and workshop services.
AEC has established strategic partnerships with global technology leaders including KCA Deutag, CPVEN, COSL, Expert Optima, NaftoServ, TRG, Jereh, and Kerui.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Action Energy Co. Appoints NIC as Market Maker to Enhance Share Liquidity
Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy
BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device.
The system is intended for the continuous monitoring of blood sugar levels and glucose trends in adults with diabetes. Based on advanced optical sensing technology, it measures glucose concentrations in the tissue fluid beneath the skin.
To support longer wear and reduce routine replacements, the system's optical sensor and overtape can be worn for up to 28 days before replacement, while the detector and charger have been designed for repeat use.
"This certification is a defining milestone for FiberSense," said Michael Tillmann, Chairman & CEO of FiberSense AG. "After years of dedicated development, our focus now turns to manufacturing scale-up and commercialization."
With CE marking achieved, FiberSense is now advancing the transition from regulatory certification to commercial readiness. The company is preparing manufacturing ramp-up, logistics, customer support and market access activities for selected launch markets, with initial orders already confirmed and first deliveries expected in late 2026.
Continuous glucose monitoring is the first regulated application of FiberSense's planned continuous multi-analyte ("CxM") platform. While the current approved intended use is continuous glucose monitoring in adults with diabetes, FiberSense continues to advance its CxM pipeline, with ketones, lactate and cortisol among the next sensor targets under evaluation.
"The FiberSense CGM System represents the first regulated application of our long-term strategy," Tillmann commented. "The goal is to explore additional opportunities in continuous biomarker sensing beyond glucose and develop a platform solution that may one day support additional analytes and applications, provided it is supported by the necessary scientific, clinical and regulatory evidence."
Contact FiberSense
+49 (0)6026 942 121
media@fibersense-cxm.com
www.fibersense-cxm.com
About FiberSense
FiberSense AG, headquartered in Basel, Switzerland, is an optical biomarker sensing company focused on health and medical technology. Building on the experience of EyeSense, a spin-off from CIBA Vision, formerly part of Novartis, FiberSense combines optical sensing expertise with the ambition to develop innovative, long-wear monitoring solutions for everyday use.
Regulatory and forward-looking note
The FiberSense CGM System is a CE-marked Class IIb medical device under Regulation (EU) 2017/745 and is intended for continuous glucose monitoring in adults with diabetes in accordance with the Instructions for Use. Product availability, first deliveries and future applications beyond glucose remain subject to applicable regulatory, quality, manufacturing, commercial and market-specific requirements.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
